Internal Limiting Membrane Peeling on Retinal Displacement

Internal Limiting Membrane Peeling Clinical Trial

Official title:

Displacement of the Retina After Idiopathic Macular Hole Surgery With Different Internal Limiting Membrane Peeling Patterns

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04655781
• Other study ID #: ILM Peeling
• Status: Completed
• Phase: N/A
• Start date: January 1, 2017
• Est. completion date: January 31, 2018

Study information

• Verified date: November 2020
• Source: The First Affiliated Hospital with Nanjing Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate displacement of the retina after idiopathic macular hole surgery with different internal limiting membrane peeling patterns.

Description:

After being informed about the study and potential risks, all patients giving written informed consent will undergo a 1-week screening period to determine eligibility for study entry. All patients with idiopathic MH will be randomly allocated into two groups, N-T group or T-N group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: January 31, 2018
• Est. primary completion date: January 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 80 Years

Eligibility

Inclusion Criteria:

Eyes with idiopathic macular hole

Exclusion Criteria:

Eyes having re-do macular hole surgery, with high myopia, with proliferative vitreoretinopathy or with a retinal detachment combined with the MH, with other macular diseases, such as age-related macular degeneration.

Related Conditions & MeSH terms

• Internal Limiting Membrane Peeling
• Retinal Perforations

Intervention

Procedure:
• idiopathic macular hole (MH) surgery
Idiopathic Macular Hole Surgery with Different Internal Limiting Membrane Peeling Patterns

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
The First Affiliated Hospital with Nanjing Medical University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	T-OD	measurement of temporal vessel to optic disc	preoperation to postoperative 6 months